Yi-min Shen

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.

Jiong Hu, Saijuan Chen, Zhu Chen, 2013, The Lancet. Oncology.

Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study

Xun Zhang, Naveen Karkada, D. Borys, 2022, Asia-Pacific journal of clinical oncology.